Singapore markets closed
Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
63,294.96 -710.39 (-1.11%) CMC Crypto 200
1,304.48 -92.06 (-6.59%)
Atreca, Inc. (BCEL)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 03:34PM EDT
| Previous close | 0.0855 |
| Open | 0.0800 |
| Bid | 0.1830 x 1000 |
| Ask | 0.1900 x 900 |
| Day's range | 0.0800 - 0.0906 |
| 52-week range | 0.0520 - 1.2640 |
| Volume | |
| Avg. volume | 921,941 |
| Market cap | 3.172M |
| Beta (5Y monthly) | 1.09 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Atreca (BCEL) Suspends Lead Drug Evaluation, Stock Falls 37%
Atreca (BCEL) suspends the development of only pipeline candidate, ATRC-101, in clinical evaluation, as part of its business restructuring efforts and cuts headcount by 40%. The stock falls 37%.
© 2024 Yahoo. All rights reserved.